eGFR by age: What is normal and when should you worry?

You open your blood test results. Most values are in black. Then you see it: eGFR 78 mL/min/1.73 m². The reference column says “>90.” Your stomach drops.

If your report includes both cystatin C and a combined equation, read cystatin C vs eGFRcr-cys before reacting to creatinine alone.

Before you start Googling “kidney failure symptoms,” take a breath. Here’s something your lab report almost certainly didn’t tell you: eGFR falls roughly 0.7-1.0 mL/min/1.73 m² per year after age 40. An eGFR of 78 that would be genuinely worrying in a 30-year-old is, statistically, the population average for a healthy 65-year-old. The number doesn’t mean the same thing at every age.

This article exists because lab reports use a one-size-fits-all reference range (“>90 is normal”) that doesn’t match how kidneys actually age. We’ll walk through what eGFR measures, what’s typical by decade, what the KDIGO stages really mean in context, and — most importantly — when a low eGFR is age-appropriate and when it’s a signal to act.

What you’ll learn:

What eGFR actually measures (and why it’s an estimate)
Typical eGFR ranges by decade, from 20s to 80s
How to tell age-normal decline from accelerated decline
When to ask your doctor for a cystatin C-based eGFR

Quick answer

In 30 seconds: eGFR above 90 mL/min/1.73 m² is labeled “normal” for everyone, but kidney filtration declines steadily with age. Most healthy people in their 60s run 60-89, and many in their 70s and 80s fall into 45-75 without any disease. KDIGO stages classify the number, but clinical concern depends on three things: your age, the trend over serial measurements, and whether albuminuria (protein in urine) is present. A single low reading in isolation — without trend, without urine testing, without context — is not a diagnosis. It’s a prompt to investigate.

What eGFR actually measures

eGFR stands for estimated glomerular filtration rate. It’s an estimate of how many milliliters of blood your kidneys filter per minute, normalized to a standard body surface area of 1.73 m².

The key word is estimated. True GFR would require injecting a filtration marker (like iohexol or inulin) and tracking its clearance over hours — impractical for routine screening. Instead, labs calculate eGFR from a blood marker (usually creatinine) combined with age and sex, plugged into an equation.

The current standard is the CKD-EPI 2021 equation, which — importantly — removed the race coefficient that earlier formulas used. When your report shows an eGFR number, this is almost certainly what’s behind it.

Why “estimate” matters

Because eGFR is derived from creatinine, and creatinine comes from muscle metabolism, the formula assumes an average body composition. If yours is unusual — very muscular, very sarcopenic, on a high-protein diet, a strict vegetarian — the estimate can drift from the truth by 10-20%.

This is why a single eGFR should not be treated as a verdict. It’s a screening number. A clinically meaningful eGFR is:

If the change is abrupt rather than age-related, use eGFR dropped suddenly to sort dehydration, lab variation, medication context, and kidney-risk signals. If creatinine still looks normal but the estimate is low, see normal creatinine but low eGFR.

Confirmed on a repeat test (ideally several weeks apart)
Interpreted alongside urine albumin (UACR)
Viewed as a trend, not a snapshot

eGFR normal range by age

Population data from CKD-EPI validation cohorts and NHANES show that mean eGFR falls predictably with each decade of adult life. The table below shows typical healthy population means — not pathological values, just what a filtering system that’s been running for decades looks like statistically.

Age (decade)	Typical healthy mean eGFR (mL/min/1.73 m²)	Lab reference (“normal”)	What’s common
20-29	110-120	≥90	Values in the 100s are the norm
30-39	105-110	≥90	Still strongly >90
40-49	95-105	≥90	Decline starts around 40
50-59	85-95	≥90	Many healthy adults drop below 90
60-69	75-85	≥90	Majority fall into “G2” (60-89) without disease
70-79	65-75	≥90	G2 and borderline G3a are common
80+	55-70	≥90	G3a frequent even without overt pathology

The mismatch is the point. Lab ranges don’t adjust for age, so a 68-year-old with eGFR 72 — a completely unremarkable value for their age — gets flagged as “below reference” and panics. The reference line is anchored to young adults.

This doesn’t mean age-related decline is “healthy” in an absolute sense — losing filtration capacity is a biological aging signal. But it does mean a mildly reduced eGFR in an older adult is usually age-appropriate, not disease.

How fast eGFR declines with age

The classic study on this is Poggio et al. (2009), which analyzed healthy kidney donors and showed that GFR decline after age 40 averages roughly 0.7-1.0 mL/min/1.73 m² per year. That’s the “normal aging” slope.

Some people decline faster. Some decline slower. The rate — not the number — is what separates benign aging from early disease. For a full breakdown of what constitutes a normal vs accelerated eGFR decline rate per year, including how to calculate your own slope, see our companion article.

Three trajectories

Normal aging: ~0.7-1.0 mL/min/1.73 m² lost per year. Over 40 years (age 40 to 80), that’s about 30-40 points total — which is why an 80-year-old with eGFR 65 can be entirely healthy.
Accelerated decline: >2 mL/min/1.73 m² per year. Suggests an active driver — uncontrolled hypertension, diabetes, NSAID overuse, autoimmune disease, obstruction.
Rapid decline: >5 mL/min/1.73 m² per year. KDIGO 2024 flags this as a criterion for specialist referral regardless of absolute eGFR value.

Why trend beats snapshot

An eGFR of 85 at age 50 can mean two very different things:

Scenario A: You were 110 at 30, 98 at 40, 85 at 50. Slope ≈ 1.0/year. Age-appropriate.
Scenario B: You were 115 at 45, 85 at 50. Slope ≈ 6.0/year. This is a 5-alarm fire.

The absolute number is identical. The clinical meaning is not. This is why keeping your historical lab values matters more than any single result.

KDIGO stages G1-G5 and what they mean

The 2024 KDIGO guidelines classify chronic kidney disease by eGFR stage, with a critical caveat: a low eGFR alone does not equal CKD. CKD requires markers of kidney damage (usually albuminuria) or eGFR <60 persisting for ≥3 months.

Stage	eGFR (mL/min/1.73 m²)	Description	Typical clinical meaning
G1	≥90	Normal or high	Only “CKD” if kidney damage present (e.g., albuminuria)
G2	60-89	Mildly decreased	Common in adults >60; pathological only with damage markers
G3a	45-59	Mild-to-moderate decrease	Monitoring; investigate cause; common in elderly
G3b	30-44	Moderate-to-severe decrease	Complications emerge; refer to nephrology
G4	15-29	Severely decreased	Prepare for renal replacement planning
G5	<15	Kidney failure	Dialysis or transplant

Notice the most important sentence: G1 and G2 are only CKD if kidney damage is also present. This is why your doctor should pair any eGFR result with a urine albumin-to-creatinine ratio (UACR). Without UACR, an isolated eGFR number tells half the story.

When to worry at your age

Here is a practical framework — not a diagnosis, but a triage.

Under 40

Your eGFR should almost always be ≥90. Anything persistently under 90 in your 20s or 30s deserves investigation: repeat testing, UACR, blood pressure check, diabetes screening, family history review. eGFR 75 at age 30 is not “borderline normal.” It’s abnormal for your age.

40-59

Expect 85-105. A single reading of 75-85 is usually fine, but repeat in a few months and check UACR. Below 75 persistently, or any downward trend >2/year, warrants a workup.

60-74

This is where lab reports cause the most needless panic. Values of 60-85 are common and often age-appropriate. Concern rises when:

eGFR is persistently <60 (G3a or worse)
UACR is elevated (≥30 mg/g)
The trend is accelerating (>2/year)
You have hypertension, diabetes, or cardiovascular disease

75+

eGFR 50-70 is frequent and not automatically pathological. The clinical question shifts: is decline accelerating? Is there albuminuria? Are medications (NSAIDs, some antihypertensives) contributing? Pure age-related G3a in an otherwise healthy 85-year-old with no proteinuria is not the same disease as G3a with proteinuria in a 55-year-old diabetic — even though the number is identical.

The three questions that actually matter

For any eGFR result at any age:

What was my eGFR last year, and the year before? (Trend)
What’s my UACR? (Kidney damage marker)
Is there a driver I can modify? (Blood pressure, glucose, NSAIDs, hydration)

The discordance problem: creatinine vs cystatin C

eGFR from creatinine (eGFRcr) has a structural weakness: creatinine depends on muscle mass. This produces two classic errors:

Overestimation in sarcopenia. A frail 80-year-old woman with 8 kg of skeletal muscle loss produces less creatinine, so her eGFRcr looks better than her actual filtration. The formula “rewards” muscle loss.
Underestimation in high muscle mass. A 95 kg competitive strength athlete produces more creatinine at baseline. eGFRcr can read 70-80 with perfectly healthy kidneys. This is the most common cause of a creatinine high but eGFR normal pattern in active adults.

The fix is cystatin C, a small protein produced by all nucleated cells and cleared by glomerular filtration. It’s far less influenced by muscle mass, diet, or physical activity. For age-specific reference values and how to interpret your result, see the cystatin C normal range by age guide.

The CKD-EPI 2021 creatinine-cystatin C combined equation (eGFRcr-cys) is more accurate than either marker alone. The 2024 KDIGO guidelines recommend adding cystatin C when:

eGFRcr is between 45-59 without other kidney damage markers (to confirm or refute CKD)
The patient has unusual muscle mass (very high or very low)
Clinical decisions hinge on the eGFR value (e.g., drug dosing, transplant eligibility)
There is “discordance” — creatinine and other signs (symptoms, imaging, BUN) don’t match

Ask your physician about cystatin C if you’re an athlete with flagged eGFRcr, elderly with significant muscle loss, or sitting in the diagnostic gray zone of 45-59.

When BUN and creatinine point in different directions, reading their ratio is the first diagnostic step. The BUN vs creatinine comparison explains what a high or low BUN/creatinine ratio reveals and when BUN gives you information that eGFR alone misses.

What to do with a low or declining eGFR

If your eGFR came back low, here’s a reasonable action sequence — always in partnership with your clinician, never as a substitute.

Don’t panic on a single reading. Transient dips from dehydration, a recent NSAID, intense exercise the day before, or high-protein meals are common. Repeat in 2-12 weeks.
Get UACR. A urine albumin-to-creatinine ratio is cheap, non-invasive, and tells you whether the filter is damaged — not just slower.
Check blood pressure. Ideally with home readings over a week. Uncontrolled hypertension is the single most modifiable driver of kidney decline.
Review metabolic status. Fasting glucose, HbA1c, lipid panel. Diabetes is the #1 global cause of kidney failure.
Audit medications and supplements. Chronic NSAIDs (ibuprofen, naproxen), some proton pump inhibitors with long-term use, high-dose creatine supplementation, and certain herbal products (aristolochic acid) can all contribute.
Hydration and protein load. Not as dramatic as people think — but persistent low water intake or extreme protein intake can bias results.
Specialist referral thresholds (KDIGO 2024): eGFR <30, rapid decline (>5/year), UACR ≥300 mg/g, resistant hypertension, unexplained electrolyte disturbances, or recurrent kidney stones.

eGFR, biological age, and longevity

Here’s the broader reason eGFR matters beyond “kidney disease yes/no”: filtration rate is one of the most reliable systemic markers of biological aging. Kidneys integrate decades of vascular, metabolic, and inflammatory history. They don’t lie about lifestyle the way weight or waist circumference sometimes do.

This is why PhenoAge, the biological age algorithm developed at Yale by Morgan Levine and colleagues, includes creatinine as one of its nine biomarkers. The algorithm doesn’t just ask “do you have CKD?” — it asks “how efficient is your filtration today, relative to a healthy 30-year-old, and what does that imply for your mortality trajectory?”

Large cohort studies — including analyses from the Atherosclerosis Risk in Communities (ARIC) study and Swedish registers — consistently show that eGFR in the low-normal range (60-75) in younger and middle-aged adults predicts higher cardiovascular mortality decades later, independent of traditional risk factors. A declining eGFR isn’t just a kidney story. It’s a whole-body aging story, signaling endothelial dysfunction, vascular stiffness, and chronic inflammation well beyond the nephron.

For longevity-oriented tracking, then, the interesting question isn’t “is my eGFR in the reference range?” — it’s “is my eGFR consistent with the filtration rate of a younger biological age, and is the trend stable?”

How SuperAge contextualizes your kidney function over time

SuperAge is built around PhenoAge, which treats creatinine (and therefore implicit eGFR) as one input in a multi-biomarker model of biological age. Instead of looking at a single eGFR value against a fixed reference line, the app plots your kidney-function trajectory against your whole-system aging trajectory.

What this means practically:

You enter your lab results over time — not just once.
SuperAge shows trend, not just snapshot. That 85 → 82 → 79 slope matters more than any individual reading.
Creatinine is interpreted in the context of eight other biomarkers (albumin, glucose, CRP, lymphocytes, MCV, RDW, alkaline phosphatase, white blood cells), so a lone flagged value doesn’t trigger false alarm.
The output is a biological age estimate that evolves as your biology does — useful for tracking the effect of interventions (blood pressure control, hydration, medication changes).

You can download SuperAge for iPhone and iPad on the App Store.

Frequently asked questions

Is eGFR 60 dangerous?

Not necessarily. eGFR 60 is the G2/G3a boundary. In a healthy 70-year-old with no albuminuria, normal blood pressure, and a stable trend, it’s often age-appropriate. In a 35-year-old diabetic with proteinuria, the same number is significantly more concerning. Context — age, trend, UACR, comorbidities — determines the meaning.

Can eGFR improve?

Yes, within limits. Transient drops (dehydration, NSAIDs, acute illness) often reverse completely. Early-stage decline tied to high blood pressure or glucose can be slowed, halted, or modestly improved with aggressive modification of those drivers. Late-stage structural damage (lost nephrons) does not regenerate — but preserving remaining function is very much possible.

Why did my eGFR drop 10 points since last year?

Common causes: dehydration on test day, a recent intense workout, a high-protein meal, recent NSAID use, a new medication (ACE inhibitors and ARBs can cause a small one-time drop that is actually protective), lab variability, or — less commonly — true progression. The right response is a repeat test in 2-12 weeks plus a UACR, not immediate alarm.

Should I ask for cystatin C?

Ask if you’re (a) very muscular or very sarcopenic, (b) sitting in the 45-59 range without other explanation, (c) making a decision where drug dosing depends on eGFR accuracy, or (d) your creatinine doesn’t fit the rest of the clinical picture. It’s not a routine test but it is widely available and inexpensive.

Does eGFR affect drug dosing?

Yes, significantly. Many medications — metformin, some antibiotics, direct oral anticoagulants, contrast agents for imaging — require dose adjustment or avoidance below certain eGFR thresholds. This is one of the main reasons accurate eGFR (via cystatin C if needed) matters even in “mild” decline.

Key takeaways

eGFR estimates kidney filtration; the current standard equation is CKD-EPI 2021 (creatinine-based, no race coefficient).
“Normal” on lab reports (>90) is anchored to young adults and doesn’t reflect age-related decline.
Healthy mean eGFR falls from ~115 in the 20s to ~65 in the 80s, losing roughly 0.7-1.0 mL/min/1.73 m² per year after 40.
KDIGO stages classify the number; clinical concern depends on age, trend, and albuminuria (UACR).
An isolated low eGFR is a screening prompt, not a diagnosis. Repeat, add UACR, review medications, check blood pressure and glucose.
Ask for cystatin C in sarcopenia, high muscle mass, or the 45-59 gray zone.
eGFR trajectory is part of biological aging — included in PhenoAge as creatinine — and reflects whole-system vascular and metabolic health.

This article is for educational purposes only and does not replace professional medical advice. If your eGFR is low or trending down, consult your healthcare provider.

Start tracking your kidney trend, not your panic number

One eGFR reading tells you almost nothing. A multi-year trend, interpreted alongside other biomarkers, tells you how your kidneys are aging relative to the rest of your biology.

SuperAge lets you log your lab results over time and computes your biological age from blood tests — including creatinine — so you can see whether your trajectory is stable, improving, or drifting. It’s the difference between reacting to a single flagged number and understanding what your body is actually doing.

Download SuperAge on the App Store and start turning isolated lab values into a longitudinal view of your kidney health and biological age.

References

Inker LA, Eneanya ND, Coresh J, et al. New creatinine- and cystatin C-based equations to estimate GFR without race. New England Journal of Medicine. 2021;385(19):1737-1749. doi:10.1056/NEJMoa2102953
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International. 2024;105(4S):S117-S314.
Poggio ED, Rule AD, Tanchanco R, et al. Demographic and clinical characteristics associated with glomerular filtration rates in living kidney donors. Kidney International. 2009;75(10):1079-1087. doi:10.1038/ki.2009.11
Levine ME, Lu AT, Quach A, et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging. 2018;10(4):573-591. doi:10.18632/aging.101414
Matsushita K, Coresh J, Sang Y, et al. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. The Lancet Diabetes & Endocrinology. 2015;3(7):514-525. doi:10.1016/S2213-8587(15)00040-6

Your eGFR is a number on a page. Your kidney aging is a trajectory. Don’t confuse the two.